Sep 14, 2022 / 04:00PM GMT
Unidentified Analyst
Hi, everyone. Thank you for joining us for our next session, on day three of our healthcare conference at HCW. I'm pleased to announce ThermoGenesis Holdings will be here and been speaking about their company. We have Chris Xu with us, CEO. This is a company that has been around for two decades or so, leading developments of cell and gene therapy and transforming basically a medical device company into optimizing how these therapies are given. And there's a strategic update today that we'll be hearing more about. And if there's time afterwards, we can have some Q&A. Go ahead; thank you.
Chris Xu - ThermoGenesis Holdings, Inc. - Chairman and CEO
Hi, everybody. I'm Chris Xu, the Chairman and CEO of ThermoGenesis Holdings, Inc. We are a NASDAQ listed, small-size public company.
So just a reminder, this presentation do contain forward-looking statement that's regulated and there by the SEC and NASDAQ. So for our company, we have been around for many decades. So the company originally was founded in 1986 as a medical device company. And over
Thermogenesis Holdings Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Sep 14, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers